Press Releases

 
Press Releases
  Date Title View
Apr 26, 2012
Albany, NY (April 26, 2012)–AMRI (NASDAQ: AMRI), a leading global contract research and manufacturing organization, announced today a key addition to the management team at its Singapore location. Saravanakumar Dhakshinamoorthy, Ph.D. joins AMRI’s Singapore site as Director of In Vitro Biology, reporting to Takeshi Yura, Ph.D....
Apr 30, 2012
Albany, NY (April 30, 2012) – AMRI (NASDAQ: AMRI) announced today SMARTSOURCING™, an approach that further focuses its research and contract manufacturing services on the various needs of the life sciences and other industries. AMRI SMARTSOURCING™ is a series of strategic sourcing...
May 2, 2012
Albany, NY (May 2, 2012)—AMRI (NASDAQ: AMRI) today announced it will issue first quarter financial results before the opening of the market on Wednesday, May 9, 2012.  Following the release of its results, the company will host a conference call and simultaneous webcast at 10 a.m. ET. The conference call can be accessed by dia...
May 7, 2012
Albany, NY (May 7, 2012) -- Albany Molecular Research, Inc. (NASDAQ: AMRI), a leading global contract research and manufacturing organization, today announced the appointment of William S. Marth to its Board of Directors. Mr. Marth has extensive experience in leading organizational and operational initiatives at global pharmaceutical companies. ...
May 9, 2012
Albany, NY (May 9, 2012) – AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2012. Financial highlights for the first quarter include:•    Sequential improvement of $6.5 million in net income as adjusted•    Signed ...
May 22, 2012
Albany, NY (May 22, 2012)–AMRI (NASDAQ: AMRI), a leading global contract research and manufacturing organization, announced today the appointment of Ian Shott as President of AMRI Europe, reporting to Thomas D’Ambra, Ph.D., chairman, president and CEO. In this newly created role, Mr. Shott will have responsibility for AMRI’s bu...
Jun 5, 2012
Albany, NY (June 5, 2012) – AMRI (NASDAQ: AMRI) announced today that its Burlington site was contracted by Cardium Therapeutics (NYSE MKT: CXM) and its subsidiary, Tissue Repair Company (“Cardium”) to manufacture sterile pre-filled syringes in support of the U.S. introduction of Excellagen®, a professional-use, formulated ...
Jun 12, 2012
Albany, NY (June 12, 2012) – AMRI (NASDAQ: AMRI) announced today that AMRI Senior Vice President, Administration and Chief Financial Officer Mark T. Frost will present at the 2012 Wells Fargo Securities Healthcare Conference on Tuesday, June 19, 2012 at 9:30 a.m. ET.An audio webcast of the corporate presentation will be available t...
Jun 19, 2012
Albany, NY (June 19, 2012) – As part of a long-term strategic plan to further AMRI’s discovery capabilities in India, AMRI (NASDAQ: AMRI), a leading global contract research and manufacturing organization, announced the hiring of two experts in medicinal and computational chemistry at its research center located in Hyderabad, India (...
Jul 19, 2012
Albany, NY (July 19, 2012) – AMRI (NASDAQ: AMRI) announced today that its subsidiary, India Pvt. Ltd. has been recognized by Abbott Health Care Pvt. Ltd. for the reliable supply of generic medications for the period from April 2011 to March 2012. This is the second year in a row that AMRI received the Silver Shield award in the category of...
Page:
1
... NextLast
= add release to Briefcase